Back to Search
Start Over
Anti-myeloma efficacy of CAR-iNKT is enhanced with a long-acting IL-7, rhIL-7-hyFc
- Source :
- Blood Advances; October 2023, Vol. 7 Issue: 20 p6009-6022, 14p
- Publication Year :
- 2023
-
Abstract
- •Human BCMA CAR-iNKTs show in vivo efficacy in a myeloma xenograft model that can be enhanced by a long-acting IL-7, rhIL-7-hyFc.•CAR-iNKTs may have lower CRS risk than CAR-Ts.
Details
- Language :
- English
- ISSN :
- 24739529 and 24739537
- Volume :
- 7
- Issue :
- 20
- Database :
- Supplemental Index
- Journal :
- Blood Advances
- Publication Type :
- Periodical
- Accession number :
- ejs63482641
- Full Text :
- https://doi.org/10.1182/bloodadvances.2023010032